Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for ADMA

Stock NameADMA Biologics Inc
TickerADMA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS0008991046

Show aggregate ADMA holdings

News associated with ADMA

Charles Schwab Investment Management Inc. Raises Position in ADMA Biologics Inc (NASDAQ:ADMA)
Charles Schwab Investment Management Inc. boosted its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The institutional investor owned 2,462,005 shares of the biotechnology company’s stock after buying an additional 21,711 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in ADMA Biologics were worth […] - 2025-08-17 06:22:54
PNC Financial Services Group Inc. Increases Stake in ADMA Biologics Inc (NASDAQ:ADMA)
PNC Financial Services Group Inc. raised its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 24.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,325 shares of the biotechnology company’s stock after acquiring an additional 4,553 shares during the […] - 2025-08-14 04:55:07
Harvest Fund Management Co. Ltd Takes Position in ADMA Biologics Inc (NASDAQ:ADMA)
Harvest Fund Management Co. Ltd bought a new stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) during the first quarter, Holdings Channel reports. The fund bought 2,611 shares of the biotechnology company’s stock, valued at approximately $52,000. A number of other hedge funds and other institutional investors have also recently made changes […] - 2025-08-01 05:32:51
ADMA Biologics Inc (NASDAQ:ADMA) Shares Acquired by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. boosted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 14.5% in the first quarter, HoldingsChannel reports. The firm owned 68,686 shares of the biotechnology company’s stock after purchasing an additional 8,682 shares during the quarter. Envestnet Asset Management Inc.’s holdings in ADMA Biologics were worth $1,363,000 […] - 2025-08-01 04:36:52
Skandinaviska Enskilda Banken AB publ Invests $35,000 in ADMA Biologics Inc (NASDAQ:ADMA)
Skandinaviska Enskilda Banken AB publ purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, HoldingsChannel reports. The firm purchased 1,773 shares of the biotechnology company’s stock, valued at approximately $35,000. A number of other hedge funds have also modified their holdings of ADMA. Vanguard Group Inc. […] - 2025-07-31 05:57:11
Avantax Advisory Services Inc. Has $2.15 Million Stake in ADMA Biologics Inc (NASDAQ:ADMA)
Avantax Advisory Services Inc. lifted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 1.8% during the 1st quarter, HoldingsChannel reports. The fund owned 108,327 shares of the biotechnology company’s stock after purchasing an additional 1,954 shares during the period. Avantax Advisory Services Inc.’s holdings in ADMA Biologics were worth $2,149,000 […] - 2025-07-31 05:16:47
Cerity Partners LLC Acquires 4,575 Shares of ADMA Biologics Inc (NASDAQ:ADMA)
Cerity Partners LLC boosted its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 10.6% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 47,703 shares of the biotechnology company’s stock after buying an additional 4,575 shares during the quarter. Cerity Partners LLC’s holdings in ADMA Biologics were worth $946,000 as […] - 2025-07-24 04:32:54
ADMA Biologics Inc (NASDAQ:ADMA) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC lessened its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 3.9% during the 1st quarter, Holdings Channel reports. The firm owned 34,423 shares of the biotechnology company’s stock after selling 1,384 shares during the quarter. Mutual of America Capital Management LLC’s holdings in ADMA Biologics […] - 2025-07-22 07:10:54
Bank of New York Mellon Corp Decreases Holdings in ADMA Biologics Inc (NASDAQ:ADMA)
Bank of New York Mellon Corp cut its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 3.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,468,609 shares of the biotechnology company’s stock after selling 52,557 shares during the quarter. Bank […] - 2025-07-17 04:42:50
ADMA Biologics Inc (NASDAQ:ADMA) Shares Acquired by Principal Financial Group Inc.
Principal Financial Group Inc. boosted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,288,121 shares of the biotechnology company’s stock after purchasing an additional 29,107 […] - 2025-07-09 05:45:05
Robeco Institutional Asset Management B.V. Boosts Holdings in ADMA Biologics Inc (NASDAQ:ADMA)
Robeco Institutional Asset Management B.V. lifted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 48.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 258,609 shares of the biotechnology company’s stock after buying an additional 84,125 shares during the […] - 2025-07-01 05:25:03
ADMA Biologics Inc (NASDAQ:ADMA) Shares Sold by Illinois Municipal Retirement Fund
Illinois Municipal Retirement Fund decreased its position in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 17.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 105,223 shares of the biotechnology company’s stock after selling 21,937 shares during the period. Illinois Municipal Retirement Fund’s holdings in ADMA […] - 2025-06-30 05:38:52
Moran Wealth Management LLC Invests $795,000 in ADMA Biologics Inc (NASDAQ:ADMA)
Moran Wealth Management LLC purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 40,056 shares of the biotechnology company’s stock, valued at approximately $795,000. A number of other large investors […] - 2025-06-27 05:14:54
State of Alaska Department of Revenue Sells 3,365 Shares of ADMA Biologics Inc (NASDAQ:ADMA)
State of Alaska Department of Revenue reduced its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 130,981 shares of the biotechnology company’s stock after selling 3,365 shares during the period. […] - 2025-06-23 04:46:52
ADMA Biologics Inc (NASDAQ:ADMA) Director Sells $3,941,719.76 in Stock
ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 194,749 shares of the business’s stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $20.24, for a total transaction of $3,941,719.76. Following the transaction, the director now owns 87,330 shares in the company, valued at […] - 2025-06-20 05:14:53
Insider Selling: ADMA Biologics Inc (NASDAQ:ADMA) Director Sells 137,931 Shares of Stock
ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 137,931 shares of ADMA Biologics stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $20.82, for a total value of $2,871,723.42. Following the completion of the sale, the director now owns 282,079 shares of the […] - 2025-06-19 05:11:05
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 6.8% on Insider Selling
ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) shares traded down 6.8% on Tuesday following insider selling activity. The company traded as low as $19.17 and last traded at $19.01. 1,700,847 shares traded hands during trading, a decline of 54% from the average session volume of 3,667,821 shares. The stock had previously closed at $20.40. […] - 2025-06-19 02:13:07
SPYV, SAWS: Big ETF Inflows
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the SPDR Portfolio S&P 500 Value ETF, which added 14,400,000 units, or a 2.8% increase week over week. Among the largest underlying components of - 2025-06-11 13:09:49
Rhumbline Advisers Buys 1,088 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
Rhumbline Advisers raised its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.2% in the 1st quarter, Holdings Channel reports. The firm owned 622,167 shares of the biotechnology company’s stock after purchasing an additional 1,088 shares during the quarter. Rhumbline Advisers’ holdings in ADMA Biologics were worth $12,344,000 at the end […] - 2025-06-09 05:26:49
Wellington Management Group LLP Sells 13,834 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
Wellington Management Group LLP lessened its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 105,459 shares of the biotechnology company’s stock after selling 13,834 shares during the quarter. Wellington Management Group […] - 2025-06-06 05:04:51
California State Teachers Retirement System Acquires 8,717 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
California State Teachers Retirement System grew its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 4.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 217,391 shares of the biotechnology company’s stock after purchasing an additional 8,717 […] - 2025-06-05 05:33:03
B. Riley Wealth Advisors Inc. Cuts Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)
B. Riley Wealth Advisors Inc. lowered its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 31.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 12,614 shares of the biotechnology company’s stock after selling 5,892 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in ADMA Biologics were worth […] - 2025-06-02 05:40:55
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $8.77 Million Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 511,526 shares of the biotechnology company’s stock after acquiring an additional 1,559 shares during […] - 2025-06-01 05:37:02
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Tidal Investments LLC
Tidal Investments LLC lessened its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 20.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,351 shares of the biotechnology company’s stock after selling 7,983 shares during the quarter. Tidal Investments LLC’s holdings […] - 2025-05-29 05:10:54
Janus Henderson Group PLC Acquires 15,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
Janus Henderson Group PLC raised its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 16.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 107,161 shares of the biotechnology company’s stock after purchasing an additional 15,000 shares during the period. Janus Henderson Group PLC’s […] - 2025-05-22 06:14:47
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.56 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 7.2% during the 4th quarter, Holdings Channel reports. The firm owned 148,638 shares of the biotechnology company’s stock after purchasing an additional 10,047 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in […] - 2025-05-21 06:14:52
ADMA Biologics (NASDAQ:ADMA) Cut to Sell at StockNews.com
StockNews.com downgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a hold rating to a sell rating in a research report released on Friday morning. Other equities analysts have also issued reports about the stock. Raymond James boosted their price objective on shares of ADMA Biologics from $25.00 to $32.00 and gave the stock […] - 2025-05-12 02:52:44
33,419 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Bought by Mariner LLC
Mariner LLC acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 33,419 shares of the biotechnology company’s stock, valued at approximately $573,000. A number of other hedge funds have also added to […] - 2025-05-01 05:55:00
Analysts Anticipate EZM Will Reach $74
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-09 07:49:44
Vanguard Group Inc. Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)
Vanguard Group Inc. increased its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,198,796 shares of the biotechnology company’s stock after buying an additional 80,302 shares during the quarter. Vanguard […] - 2025-04-04 05:04:57

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc ADMA holdings

DateNumber of ADMA Shares HeldBase Market Value of ADMA SharesLocal Market Value of ADMA SharesChange in ADMA Shares HeldChange in ADMA Base ValueCurrent Price per ADMA Share HeldPrevious Price per ADMA Share Held
2025-09-26 (Friday)51,356USD 801,667USD 801,667
2025-09-25 (Thursday)51,356USD 786,774ADMA holding decreased by -17461USD 786,7740USD -17,461 USD 15.32 USD 15.66
2025-09-24 (Wednesday)51,356USD 804,235USD 804,235
2025-09-17 (Wednesday)51,024USD 793,933ADMA holding decreased by -6634USD 793,9330USD -6,634 USD 15.56 USD 15.69
2025-09-16 (Tuesday)51,024USD 800,567USD 800,567
2025-09-12 (Friday)50,692USD 816,648USD 816,648
2025-09-11 (Thursday)50,692USD 816,648USD 816,648
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ADMA by Blackrock for IE00B3VWM098

Show aggregate share trades of ADMA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-166 17.100* 18.92 Profit of 3,140 on sale
2025-07-31BUY498 18.700* 18.93
2025-06-30SELL-332 18.210* 19.07 Profit of 6,331 on sale
2025-06-25SELL-166 17.600* 19.09 Profit of 3,169 on sale
2025-06-20SELL-332 17.740* 19.12 Profit of 6,347 on sale
2025-05-30BUY22,812 19.840* 18.99
2025-05-23BUY87 20.420* 18.94
2025-05-19SELL-87 20.190* 18.90 Profit of 1,644 on sale
2025-05-15SELL-261 19.200* 18.89 Profit of 4,930 on sale
2025-05-12SELL-87 20.450* 18.86 Profit of 1,641 on sale
2025-05-09SELL-87 19.980* 18.85 Profit of 1,640 on sale
2025-04-30SELL-87 23.800* 18.56 Profit of 1,614 on sale
2025-04-24SELL-174 22.330* 18.37 Profit of 3,196 on sale
2025-04-17SELL-87 21.310* 18.23 Profit of 1,586 on sale
2025-04-15SELL-261 22.150* 18.15 Profit of 4,737 on sale
2025-04-14SELL-261 20.910* 18.12 Profit of 4,729 on sale
2025-04-09SELL-348 19.390* 18.08 Profit of 6,293 on sale
2025-04-07SELL-609 18.400* 18.08 Profit of 11,013 on sale
2025-04-04SELL-870 18.010* 18.08 Profit of 15,734 on sale
2025-03-31BUY87 19.840* 18.02
2025-03-19SELL-174 20.610* 17.80 Profit of 3,096 on sale
2025-03-14SELL-528 18.430* 17.76 Profit of 9,378 on sale
2025-03-13SELL-176 17.910* 17.76 Profit of 3,126 on sale
2025-03-12SELL-2,992 18.500* 17.75 Profit of 53,103 on sale
2025-03-07SELL-176 17.020* 17.78 Profit of 3,130 on sale
2025-03-06SELL-264 16.910* 17.80 Profit of 4,698 on sale
2025-03-03SELL-88 15.830* 17.84 Profit of 1,570 on sale
2025-02-28SELL-528 16.390* 17.87 Profit of 9,433 on sale
2025-02-26SELL-88 15.780* 17.94 Profit of 1,579 on sale
2025-02-25SELL-264 15.440* 17.99 Profit of 4,748 on sale
2025-02-18BUY440 16.170* 18.18
2025-02-13BUY88 16.080* 18.31
2025-02-12BUY88 15.840* 18.36
2025-02-11BUY264 15.880* 18.41
2025-02-06BUY792 16.920* 18.52
2025-01-27BUY88 16.190* 18.98
2024-12-30BUY440 17.490* 19.22
2024-12-06BUY352 19.820* 19.21
2024-12-05BUY88 19.315* 19.20
2024-12-04BUY440 19.950* 19.18
2024-11-29BUY440 20.110* 19.09
2024-11-27BUY352 21.830* 18.85
2024-11-26BUY88 21.820* 18.72
2024-11-21BUY435 21.300* 18.31
2024-11-20BUY261 21.370* 18.14
2024-11-18BUY1,044 19.540* 17.89
2024-11-12BUY696 21.780* 17.63
2024-11-08BUY435 22.620* 17.28
2024-11-07BUY1,305 19.720* 17.09
2024-11-06BUY174 19.670* 16.87
2024-10-31BUY87 16.310* 16.11
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ADMA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19554,4137371,447,50538.3%
2025-09-18435,18110,1241,445,62830.1%
2025-09-17543,9082,280876,53062.1%
2025-09-16737,8035391,354,53254.5%
2025-09-15675,6322,5991,376,96449.1%
2025-09-12712,7928981,337,20453.3%
2025-09-11245,17551674,95336.3%
2025-09-10472,1722,2821,124,27042.0%
2025-09-09884,0891,1001,519,25258.2%
2025-09-08766,4091,6581,629,50347.0%
2025-09-05645,121531,156,33255.8%
2025-09-04900,1606,7502,273,75239.6%
2025-09-031,231,9471,3552,927,05342.1%
2025-09-02810,2571,2362,109,45038.4%
2025-08-29303,2896,797702,32943.2%
2025-08-28274,5611,158997,20827.5%
2025-08-27503,2709541,369,10136.8%
2025-08-26256,0120578,12344.3%
2025-08-25513,5452,143940,74954.6%
2025-08-22377,885799825,86145.8%
2025-08-21199,294182788,29625.3%
2025-08-20360,6021,094570,04363.3%
2025-08-19453,129411860,62352.7%
2025-08-18528,8974,2791,092,00848.4%
2025-08-15578,165267914,92463.2%
2025-08-14587,5131,054927,27263.4%
2025-08-13567,7804621,138,20949.9%
2025-08-12674,25402,086,06032.3%
2025-08-111,452,3823003,031,83047.9%
2025-08-08810,29145,4061,626,47849.8%
2025-08-073,063,75385,4145,058,74260.6%
2025-08-06655,2761281,327,47249.4%
2025-08-05428,337955888,07948.2%
2025-08-04446,905400948,77047.1%
2025-08-01502,020917776,35664.7%
2025-07-31398,016208690,21957.7%
2025-07-30628,3311,9091,119,59756.1%
2025-07-29559,0111,732873,51864.0%
2025-07-28537,514318921,68558.3%
2025-07-25495,3174801,415,36735.0%
2025-07-24389,6171,948699,97655.7%
2025-07-23383,7834,2301,967,70119.5%
2025-07-22363,5593,539788,35146.1%
2025-07-21437,9014,001781,01956.1%
2025-07-18518,6855,2371,840,21228.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.